Breathalyser technology able to rapidly diagnose tuberculosis and lung cancer could one day find its way into doctors’ surgeries, thanks to work carried out by engineers from Siemens in Germany. The system, developed by a team from the company’s Corporate Technology research base, uses a quadrupole mass spectrometer to analyse the molecules in a patient’s breath, which can be reliable indicators of a range of different medical conditions.
